Core Scientific Statistics
Total Valuation
Core Scientific has a market cap or net worth of $3.02 billion. The enterprise value is $3.33 billion.
Important Dates
The next confirmed earnings date is Wednesday, February 26, 2025, after market close.
| Earnings Date | Feb 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Core Scientific has 279.25 million shares outstanding. The number of shares has decreased by -25.81% in one year.
| Current Share Class | 279.25M |
| Shares Outstanding | 279.25M |
| Shares Change (YoY) | -25.81% |
| Shares Change (QoQ) | +63.85% |
| Owned by Insiders (%) | 6.99% |
| Owned by Institutions (%) | 82.99% |
| Float | 236.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 24.90 |
| PS Ratio | 5.54 |
| Forward PS | 5.74 |
| PB Ratio | -4.13 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 59.38 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.97 |
| EV / EBITDA | 21.87 |
| EV / EBIT | 98.13 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.63
| Current Ratio | 3.63 |
| Quick Ratio | 3.39 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.51 |
| Debt / FCF | n/a |
| Interest Coverage | 0.28 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 2.61% |
| Return on Invested Capital (ROIC) | 12.98% |
| Return on Capital Employed (ROCE) | 4.02% |
| Revenue Per Employee | $1.95M |
| Profits Per Employee | -$3.96M |
| Employee Count | 286 |
| Asset Turnover | 0.69 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Core Scientific has paid $820,000 in taxes.
| Income Tax | 820,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +204.65% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +204.65% |
| 50-Day Moving Average | 13.85 |
| 200-Day Moving Average | 11.52 |
| Relative Strength Index (RSI) | 31.71 |
| Average Volume (20 Days) | 12,106,844 |
Short Selling Information
The latest short interest is 42.01 million, so 15.04% of the outstanding shares have been sold short.
| Short Interest | 42.01M |
| Short Previous Month | 42.46M |
| Short % of Shares Out | 15.04% |
| Short % of Float | 17.79% |
| Short Ratio (days to cover) | 4.43 |
Income Statement
In the last 12 months, Core Scientific had revenue of $557.68 million and -$1.13 billion in losses. Loss per share was -$3.97.
| Revenue | 557.68M |
| Gross Profit | 163.54M |
| Operating Income | 33.94M |
| Pretax Income | -830.24M |
| Net Income | -1.13B |
| EBITDA | 152.31M |
| EBIT | 33.94M |
| Loss Per Share | -$3.97 |
Full Income StatementBalance Sheet
The company has $253.02 million in cash and $567.74 million in debt, giving a net cash position of -$314.72 million or -$1.13 per share.
| Cash & Cash Equivalents | 253.02M |
| Total Debt | 567.74M |
| Net Cash | -314.72M |
| Net Cash Per Share | -$1.13 |
| Equity (Book Value) | -729.40M |
| Book Value Per Share | -2.61 |
| Working Capital | 201.34M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $50.79 million and capital expenditures -$77.85 million, giving a free cash flow of -$27.05 million.
| Operating Cash Flow | 50.79M |
| Capital Expenditures | -77.85M |
| Free Cash Flow | -27.05M |
| FCF Per Share | -$0.10 |
Full Cash Flow StatementMargins
Gross margin is 29.32%, with operating and profit margins of 6.09% and -223.28%.
| Gross Margin | 29.32% |
| Operating Margin | 6.09% |
| Pretax Margin | -223.13% |
| Profit Margin | -223.28% |
| EBITDA Margin | 27.31% |
| EBIT Margin | 6.09% |
| FCF Margin | n/a |
Dividends & Yields
Core Scientific does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 25.81% |
| Shareholder Yield | 25.81% |
| Earnings Yield | -37.58% |
| FCF Yield | -0.90% |
Analyst Forecast
The average price target for Core Scientific is $19.08, which is 76.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.08 |
| Price Target Difference | 76.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 36.81% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Core Scientific has an Altman Z-Score of -3.79 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.79 |
| Piotroski F-Score | 7 |